1 |
Zheng Y, Xue M, Cai Y, et al. Hospitalizations for peptic ulcer disease in China: Current features and outcomes [J]. J Gastroenterol Hepatol, 2020, 35(12): 2122-2130.
|
2 |
Ren S, Cai P, Liu Y, et al. Prevalence of Helicobacter pylori infection in China: A systematic review and meta-analysis [J]. J Gastroenterol Hepatol, 2022, 37(3): 464-470.
|
3 |
蒋丽. 影响上消化道溃疡合并出血相关危险因素分析 [J/CD]. 临床医药文献电子杂志, 2018, 5(95): 89-92.
|
4 |
Sostres C, Carrera-Lasfuentes P, Benito R, et al. Peptic Ulcer Bleeding Risk. The role of helicobacter pylori infection in NSAID/low-dose aspirin users [J]. Am J Gastroenterol, 2015, 110(5):684-689.
|
5 |
中华医学会消化病学分会幽门螺杆菌学组. 第六次全国幽门螺杆菌感染处理共识报告(非根除治疗部分) [J]. 中华消化杂志, 2022, 42(5): 289-303.
|
6 |
王锦萍, 崔毅, 王锦辉, 等. 上消化道出血15年临床流行病学变化趋势 [J]. 中华胃肠外科杂志, 2017, 20(4): 425-431.
|
7 |
Hawkey C, Avery A, Coupland CAC, et al. Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial [J]. Lancet, 2022, 400(10363): 1597-1606.
|
8 |
Rostom A, Moayyedi P, Hunt R. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks [J]. Aliment Pharmacol Ther, 2009, 29(5): 481-496.
|
9 |
苏醒, 范炯同, 黄圣宴, 等. 消化性溃疡出血危险因素的Meta分析 [J]. 中国老年学杂志, 2020, 40(18): 3883-3886.
|
10 |
Kumar NL, Claggett BL, Cohen AJ, et al. Association between an increase in blood urea nitrogen at 24 hours and worse outcomes in acute nonvariceal upper GI bleeding [J]. Gastrointest Endosc, 2017, 86(6): 1022-1027.e1.
|
11 |
Park SJ, Park H, Lee YC, et al. Effect of scheduled second-look endoscopy on peptic ulcer bleeding: a prospective randomized multicenter trial [J]. Gastrointest Endosc, 2018, 87(2): 457-465.
|
12 |
Jensen DM, Eklund S, Persson T, et al. Reassessment of rebleeding risk of Forrest IB (Oozing) peptic ulcer bleeding in a large international randomized trial [J]. Am J Gastroenterol, 2017, 112(3): 441-446.
|
13 |
Elmunzer BJ, Young SD, Inadomi JM, et al. Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers [J]. Am J Gastroenterol, 2008, 103(10): 2625-2632; quiz 2633.
|
14 |
García-Iglesias P, Villoria A, Suarez D, et al. Meta-analysis: predictors of rebleeding after endoscopic treatment for bleeding peptic ulcer [J]. Aliment Pharmacol Ther, 2011, 34(8): 888-900.
|
15 |
Bai Y, Du YQ, Wang D, et al. Peptic ulcer bleeding in China: A multicenter endoscopic survey of 1006 patients [J]. J Dig Dis, 2014, 15(1): 5-11.
|
16 |
Camus M, Jensen DM, Kovacs TO, et al. Independent risk factors of 30-day outcomes in 1264 patients with peptic ulcer bleeding in the USA: Large ulcers do worse [J]. Aliment Pharmacol Ther, 2016, 43(10): 1080-1089.
|
17 |
Park SJ, Park H, Lee YC, et al. Effect of scheduled second-look endoscopy on peptic ulcer bleeding: a prospective randomized multicenter trial [J]. Gastrointest Endosc, 2018, 87(2): 457-465.
|
18 |
Vergara M, Bennett C, Calvet X, et al. Epinephrine injection versus epinephrine injection and a second endoscopic method in high-risk bleeding ulcers [J]. Cochrane Database Syst Rev, 2014, 13(10): CD005584.
|